For example, the SELECT trial clearly demonstrated that semaglutide significantly reduces the risk of major adverse cardiovascular events (MACE), leading to FDA approval for lowering the risk of cardiovascular death, myocardial infarction, or stroke in overweight or obese adults with established cardiovascular disease ( ) for reducing the risk of kidney failure and disease progression in patients with diabetes and chronic kidney disease (CKD), making it the first GLP-1 agent indicated for the treatment of CKD ( In parallel with these clinical advances, the growth of academic output has been striking
Yes, 37.5% of the women experienced skin lightening
Absolute contraindications Pregnancy and breastfeeding (no injectables, no energy-based devices)
Mistake 4: not labeling the vial You reconstitute a vial, put it in the fridge, and a week later you cannot remember whether you added 1mL or 2mL
156(2 Pt 1):425-30
Side effects of HT medications may include breast tenderness, fluid retention or bloating, headaches, breakthrough bleeding (bleeding or spotting between periods), and mood changes or irritability
